1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary

3.1. Introduction
3.2. Market Outlook
3.3. Diagnostic Test Outlook
3.4. Treatment Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview

4.1. Introduction

5. Market Dynamics

5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Market Insights

6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations

7. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, By Diagnostic Test

7.1. Introduction
7.2. Bone Marrow Examination
7.3. Complete Blood Count Test (CBC)
7.4. Flow Cytometry
7.5. Lactate Dehydrogenase Test (LDH)
7.6. Urine Test for Hemosiderin

8. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, By Treatment

8.1. Introduction
8.2. Blood Transfusion
8.3. Medication
8.4. Stem Cell Transplant

9. Americas Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market

11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

13.1. Achillion Pharmaceuticals
13.2. Akari Therapeutics
13.3. Alexion Pharmaceuticals, lnc.
13.4. Alnylam Pharmaceuticals, Inc.
13.5. Apellis Pharmaceuticals
13.6. F. Hoffmann-La Roche AG
13.7. Novartis AG
13.8. Ra Pharmaceuticals
13.9. Regeneron Pharmaceuticals, Inc.

14. Appendix

14.1. Discussion Guide

List of Figures

FIGURE 1. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 7. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 8. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 9. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2019 VS 2025 (%)
FIGURE 14. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2019 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2025
FIGURE 16. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY BONE MARROW EXAMINATION, 2019 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY COMPLETE BLOOD COUNT TEST (CBC), 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY FLOW CYTOMETRY, 2019 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY LACTATE DEHYDROGENASE TEST (LDH), 2019 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY URINE TEST FOR HEMOSIDERIN, 2019 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2019 VS 2025 (%)
FIGURE 22. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2019 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2025
FIGURE 24. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY BLOOD TRANSFUSION, 2019 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY MEDICATION, 2019 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY STEM CELL TRANSPLANT, 2019 VS 2025 (USD MILLION)
FIGURE 27. AMERICAS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 28. AMERICAS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. ARGENTINA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 31. BRAZIL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 32. CANADA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 33. MEXICO PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 34. UNITED STATES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 35. ASIA-PACIFIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 36. ASIA-PACIFIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. AUSTRALIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 39. CHINA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 40. INDIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 41. INDONESIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 42. JAPAN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 43. MALAYSIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 44. PHILIPPINES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 45. SOUTH KOREA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 46. THAILAND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. FRANCE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 51. GERMANY PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 52. ITALY PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 53. NETHERLANDS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 54. QATAR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 55. RUSSIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 56. SAUDI ARABIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 57. SOUTH AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 58. SPAIN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 59. UNITED ARAB EMIRATES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 60. UNITED KINGDOM PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 61. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY BONE MARROW EXAMINATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY COMPLETE BLOOD COUNT TEST (CBC), BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY LACTATE DEHYDROGENASE TEST (LDH), BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY URINE TEST FOR HEMOSIDERIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY BLOOD TRANSFUSION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY MEDICATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY STEM CELL TRANSPLANT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 13. AMERICAS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 14. AMERICAS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 15. AMERICAS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 16. ARGENTINA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 17. ARGENTINA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 18. BRAZIL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 19. BRAZIL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 20. CANADA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 21. CANADA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 22. MEXICO PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 23. MEXICO PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 24. UNITED STATES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 25. UNITED STATES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 26. ASIA-PACIFIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 27. ASIA-PACIFIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 28. ASIA-PACIFIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 29. AUSTRALIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 30. AUSTRALIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 31. CHINA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 32. CHINA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 33. INDIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 34. INDIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 35. INDONESIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 36. INDONESIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 37. JAPAN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 38. JAPAN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 39. MALAYSIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 40. MALAYSIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 41. PHILIPPINES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 42. PHILIPPINES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 43. SOUTH KOREA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 44. SOUTH KOREA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 45. THAILAND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 46. THAILAND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 50. FRANCE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 51. FRANCE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 52. GERMANY PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 53. GERMANY PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 54. ITALY PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 55. ITALY PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 56. NETHERLANDS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 57. NETHERLANDS PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 58. QATAR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 59. QATAR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 60. RUSSIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 61. RUSSIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 62. SAUDI ARABIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 63. SAUDI ARABIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 64. SOUTH AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 65. SOUTH AFRICA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 66. SPAIN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 67. SPAIN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 68. UNITED ARAB EMIRATES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 69. UNITED ARAB EMIRATES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 70. UNITED KINGDOM PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY DIAGNOSTIC TEST, 2017-2025 (USD MILLION)
TABLE 71. UNITED KINGDOM PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET SIZE, BY TREATMENT, 2017-2025 (USD MILLION)
TABLE 72. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: SCORES
TABLE 73. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: BUSINESS STRATEGY
TABLE 74. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 75. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: RANKING
TABLE 76. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: MERGER & ACQUISITION
TABLE 77. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 78. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 79. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 80. GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION

Companies Mentioned

Achillion Pharmaceuticals
Akari Therapeutics
Alexion Pharmaceuticals, lnc.
Alnylam Pharmaceuticals, Inc.
Apellis Pharmaceuticals
F. Hoffmann-La Roche AG
Novartis AG
Ra Pharmaceuticals
Regeneron Pharmaceuticals, Inc.